Lilly(Eli) & Co (NYSE: LLY) started the day on Wednesday, with a price decrease of -0.14% at $788.19, before settling in for the price of $789.32 at the close. Taking a more long-term approach, LLY posted a 52-week range of $561.65-$972.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 9.91%. Meanwhile, its Annual Earning per share during the time was 13.74%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 109.82%. This publicly-traded company’s shares outstanding now amounts to $949.38 million, simultaneously with a float of $850.67 million. The organization now has a market capitalization sitting at $747.17 billion. At the time of writing, stock’s 50-day Moving Average stood at $856.91, while the 200-day Moving Average is $836.39.
Lilly(Eli) & Co (LLY) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – General Industry. Lilly(Eli) & Co’s current insider ownership accounts for 10.39%, in contrast to 72.75% institutional ownership. Preceding that transaction, on Nov 08 ’24, Company’s SVP, Finance, & CAO sold 900 for 803.38, making the whole transaction’s value amount to 723,042. This particular insider is now the holder of 5,480 in total.
Lilly(Eli) & Co (LLY) Earnings and Revenue Records
Lilly(Eli) & Co’s EPS increase for this current 12-month fiscal period is 109.82% and is forecasted to reach 22.52 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 33.00% through the next 5 years, which can be compared against the 13.74% growth it accomplished over the previous five years trading on the market.
Lilly(Eli) & Co (NYSE: LLY) Trading Performance Indicators
Let’s observe the current performance indicators for Lilly(Eli) & Co (LLY). It’s Quick Ratio in the last reported quarter now stands at 0.97. The Stock has managed to achieve an average true range (ATR) of 25.79. Alongside those numbers, its PE Ratio stands at $86.22, and its Beta score is 0.40. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 18.28. Similarly, its price to free cash flow for trailing twelve months is now 533.77.
In the same vein, LLY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 9.14, a figure that is expected to reach 5.47 in the next quarter, and analysts are predicting that it will be 22.52 at the market close of one year from today.
Technical Analysis of Lilly(Eli) & Co (LLY)
If we take a close look at the recent performances of Lilly(Eli) & Co (NYSE: LLY), its last 5-days Average volume was 4.64 million that shows progress from its year to date volume of 3.22 million. During the previous 9 days, stock’s Stochastic %D was recorded 65.68% While, its Average True Range was 26.13.
Raw Stochastic average of Lilly(Eli) & Co (LLY) in the period of the previous 100 days is set at 29.41%, which indicates a major fall in contrast to 56.52% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 41.64% that was higher than 36.41% volatility it exhibited in the past 100-days period.
